These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23777469)
1. Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy. Kavanagh DH; Savage DA; Patterson CC; McKnight AJ; Crean JK; Maxwell AP; McKay GJ; BMC Nephrol; 2013 Jun; 14():126. PubMed ID: 23777469 [TBL] [Abstract][Full Text] [Related]
2. Association analysis of canonical Wnt signalling genes in diabetic nephropathy. Kavanagh DH; Savage DA; Patterson CC; McKnight AJ; Crean JK; Maxwell AP; McKay GJ; PLoS One; 2011; 6(8):e23904. PubMed ID: 21876774 [TBL] [Abstract][Full Text] [Related]
3. Association analysis of dyslipidemia-related genes in diabetic nephropathy. McKay GJ; Savage DA; Patterson CC; Lewis G; McKnight AJ; Maxwell AP; PLoS One; 2013; 8(3):e58472. PubMed ID: 23555584 [TBL] [Abstract][Full Text] [Related]
4. Association analysis of Notch pathway signalling genes in diabetic nephropathy. Kavanagh D; McKay GJ; Patterson CC; McKnight AJ; Maxwell AP; Savage DA; Diabetologia; 2011 Feb; 54(2):334-8. PubMed ID: 21103979 [TBL] [Abstract][Full Text] [Related]
5. Identified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese population. Liao LN; Chen CC; Wu FY; Lin CC; Hsiao JH; Chang CT; Kardia SL; Li TC; Tsai FJ BMC Genet; 2014 Oct; 15():113. PubMed ID: 25359423 [TBL] [Abstract][Full Text] [Related]
6. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680 [TBL] [Abstract][Full Text] [Related]
7. Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. Kanková K; Stejskalová A; Pácal L; Tschoplová S; Hertlová M; Krusová D; Izakovicová-Hollá L; Beránek M; Vasků A; Barral S; Ott J Diabetologia; 2007 May; 50(5):990-9. PubMed ID: 17345061 [TBL] [Abstract][Full Text] [Related]
8. Association of WNT Pathway Genes With Nonsyndromic Cleft Lip With or Without Cleft Palate. Vijayan V; Ummer R; Weber R; Silva R; Letra A Cleft Palate Craniofac J; 2018 Mar; 55(3):335-341. PubMed ID: 29437498 [TBL] [Abstract][Full Text] [Related]
9. IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from western Mexico. Chavarria-Buenrostro LE; Hernandez-Bello J; Muñoz-Valle JF; Macias-Barragan J; Hernandez-Carrillo LB; Topete-Reyes JF; Parra-Michel R; Ramirez-Dueñas MG; Sanchez-Hernandez PE; Pereira-Suarez AL; Oceguera-Contreras E; Montoya-Buelna M J Clin Lab Anal; 2019 Feb; 33(2):e22691. PubMed ID: 30345559 [TBL] [Abstract][Full Text] [Related]
10. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy. Martin RJ; McKnight AJ; Patterson CC; Sadlier DM; Maxwell AP; Nephrol Dial Transplant; 2010 Feb; 25(2):497-503. PubMed ID: 19783860 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways. Nazir N; Siddiqui K; Al-Qasim S; Al-Naqeb D BMC Med Genet; 2014 Oct; 15():103. PubMed ID: 25280384 [TBL] [Abstract][Full Text] [Related]
12. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy. Pettigrew KA; McKnight AJ; Patterson CC; Kilner J; Sadlier DM; Maxwell AP J Hum Genet; 2010 Apr; 55(4):248-51. PubMed ID: 20203694 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy. McKay GJ; Kavanagh DH; Crean JK; Maxwell AP J Diabetes Res; 2016; 2016():7684038. PubMed ID: 26697505 [TBL] [Abstract][Full Text] [Related]
14. Haplotypes in vitamin D receptor gene encode risk in diabetic nephropathy. Razi F; Meshkani MA; Zarrabi F; Sadr M; Asgarbeik S; Bandarian F; Forouzanfar K; Amoli MM Gene; 2019 Jan; 683():149-152. PubMed ID: 30315926 [TBL] [Abstract][Full Text] [Related]
15. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression. Hameed I; Masoodi SR; Malik PA; Mir SA; Ghazanfar K; Ganai BA Gene; 2018 Jun; 661():51-59. PubMed ID: 29605608 [TBL] [Abstract][Full Text] [Related]
16. Examination of association with candidate genes for diabetic nephropathy in a Mexican American population. Kim S; Abboud HE; Pahl MV; Tayek J; Snyder S; Tamkin J; Alcorn H; Ipp E; Nast CC; Elston RC; Iyengar SK; Adler SG Clin J Am Soc Nephrol; 2010 Jun; 5(6):1072-8. PubMed ID: 20299368 [TBL] [Abstract][Full Text] [Related]
17. Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population. Wu HY; Wang Y; Chen M; Zhang X; Wang D; Pan Y; Li L; Liu D; Dai XM J Endocrinol Invest; 2013 May; 36(5):298-302. PubMed ID: 22842811 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431 [TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients. Mtiraoui N; Ezzidi I; Turki A; Chaieb M; Mahjoub T; Almawi WY J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):572-80. PubMed ID: 21421655 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide pathway analysis for diabetic nephropathy in type 1 diabetes. Lee YH; Song GG Endocr Res; 2016; 41(1):21-7. PubMed ID: 26167956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]